AVM Biotech
Terrence (Terry) Kopp had a successful 27-year history in marketing and sales with a major programming network in cable TV and has served in investor relations leadership for AVM Biotechnology since 2014, including leading series B, C, and D raises.
This person is not in the org chart
This person is not in any offices
AVM Biotech
5 followers
AVM is a development-stage biotech company advancing the research, development and commercialization of game-changing stem cell technologies for high unmet medical needs in regenerative medicine, cancer treatment recovery, safer iPS cell culturing and treatment, and fully human biologics, including patient-specific biologics for personalized medicine (“Boutique Biologics™”) in orphan diseases.